5-Amino-1MQ 50mg x60 Capsules
Oral 5-Amino-1MQ Capsules for Convenient NNMT Research
5-Amino-1MQ in convenient 50mg oral capsules (60 count) for oral administration research, enabling oral bioavailability and chronic dosing protocol studies.
Oral 5-Amino-1MQ Capsules for Convenient NNMT Research
Encapsulated 5-Amino-1MQ enables oral route research investigating NNMT inhibition via enteral delivery. 60 capsules at 50mg provides a complete 2-month oral research protocol.
As one of the most studied compounds in the metabolic & fat loss research space, 5-Amino-1MQ has attracted sustained scientific interest across Oral NNMT research, Chronic metabolic dosing studies. Peer-reviewed evidence indicates that 60 capsules for 2-month oral protocol, which has positioned 5-Amino-1MQ as a reference standard for researchers exploring oral nnmt research outcomes. The compound's selectivity and documented tolerability in preclinical models have contributed to a rapidly growing body of literature over the past decade.
5-Amino-1MQ Documented Benefits: 2 Documented Mechanisms
Oral Administration
Convenient capsule form for oral NNMT inhibition and metabolic research.
2-Month Supply
60 capsules at 50mg provides complete chronic oral dosing protocol supply.
How 5-Amino-1MQ Works: Molecular Mechanism & Pathway
Same NNMT inhibition mechanism via oral administration route.
The 2 primary research pathways identified for 5-Amino-1MQ — Oral Administration, 2-Month Supply — collectively point to a compound with pleiotropic activity across interconnected biological systems. Studies have further shown that oral bioavailability research, reinforcing the mechanistic picture established in earlier cell-line work. Unlike single-pathway agents, 5-Amino-1MQ's broad receptor engagement profile continues to generate hypotheses for novel applications beyond its originally characterized use cases.
Research Protocols & Compound Combinations
5-Amino-1MQ is routinely studied alongside NAD+ and 5-Amino-1MQ in metabolic & fat loss-focused compound panels. Researchers investigating oral nnmt research have found that pairing compounds with complementary receptor profiles can produce additive results while keeping individual doses within well-characterized ranges. Preliminary evidence that 98.9% purity has informed several of these multi-compound protocol designs.
Purity, Testing & Research Grade Standards
All 5-Amino-1MQ research material offered through this catalog is manufactured under controlled conditions and independently verified by a third-party laboratory prior to release. Each lot undergoes High-Performance Liquid Chromatography (HPLC) analysis to confirm ≥98% purity, with identity confirmed via mass spectrometry. The accompanying Certificate of Analysis (CoA) documents the exact purity, molecular weight confirmation, and lot-specific testing date — data that should accompany any reproducible research protocol. Lyophilized powder formulation ensures maximum stability during shipping and storage at −20°C long-term or 4°C for short-term use.
◈ Key Highlights
- 60 capsules for 2-month oral protocol
- Oral bioavailability research
- 98.9% purity
Ideal For
- Oral NNMT research
- Chronic metabolic dosing studies
Intended for laboratory use only. Not for human or animal consumption. Not FDA approved. Handle in appropriate lab settings only.
What the Research Shows
The following data points are derived from peer-reviewed preclinical and clinical studies on 5-Amino-1MQ. All studies cited in compound profiles are indexed in PubMed or published in peer-reviewed journals.
60 capsules for 2-month oral protocol
Oral bioavailability research
98.9% purity
Third-Party Verified Every Batch
Each vial of 5-Amino-1MQ is independently tested by a third-party laboratory before fulfillment. You receive the actual CoA (Certificate of Analysis) documentation with your order.
